 | • レポートコード：GIR-107A14655 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、認知増強薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。認知増強薬の種類別市場規模（経口、注射）、用途別市場規模（病院薬局、ドラッグストア、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・認知増強薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Accelerated Intelligence、Cognition Therapeutics、Cogstate、HVMN、Biogen Idec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：病院薬局、ドラッグストア、小売薬局 ・認知増強薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・認知増強薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・認知増強薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・認知増強薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・認知増強薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cognition-Enhancing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cognition-Enhancing Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cognition-Enhancing Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cognition-Enhancing Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital Pharmacies
Drug Stores
Retail Pharmacies
The key market players for global Cognition-Enhancing Drugs market are listed below:
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cognition-Enhancing Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cognition-Enhancing Drugs, with price, sales, revenue and global market share of Cognition-Enhancing Drugs in 2018 and 2019.
Chapter 3, the Cognition-Enhancing Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cognition-Enhancing Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cognition-Enhancing Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cognition-Enhancing Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cognition-Enhancing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cognition-Enhancing Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Cognition-Enhancing Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Global Cognition-Enhancing Drugs Market Size & Forecast
1.4.1 Global Cognition-Enhancing Drugs Sales in Value (2016-2026))
1.4.2 Global Cognition-Enhancing Drugs Sales in Volume (2016-2026)
1.4.3 Global Cognition-Enhancing Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Cognition-Enhancing Drugs Production Capacity Analysis
1.5.1 Global Cognition-Enhancing Drugs Total Production Capacity (2016-2026)
1.5.2 Global Cognition-Enhancing Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cognition-Enhancing Drugs Market Drivers
1.6.2 Cognition-Enhancing Drugs Market Restraints
1.6.3 Cognition-Enhancing Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Accelerated Intelligence
2.1.1 Accelerated Intelligence Details
2.1.2 Accelerated Intelligence Major Business
2.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Product and Services
2.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Cognition Therapeutics
2.2.1 Cognition Therapeutics Details
2.2.2 Cognition Therapeutics Major Business
2.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Product and Services
2.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cogstate
2.3.1 Cogstate Details
2.3.2 Cogstate Major Business
2.3.3 Cogstate Cognition-Enhancing Drugs Product and Services
2.3.4 Cogstate Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 HVMN
2.4.1 HVMN Details
2.4.2 HVMN Major Business
2.4.3 HVMN Cognition-Enhancing Drugs Product and Services
2.4.4 HVMN Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Biogen Idec
2.5.1 Biogen Idec Details
2.5.2 Biogen Idec Major Business
2.5.3 Biogen Idec Cognition-Enhancing Drugs Product and Services
2.5.4 Biogen Idec Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cognition-Enhancing Drugs Sales by Manufacturer
3.1 Global Cognition-Enhancing Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cognition-Enhancing Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cognition-Enhancing Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Cognition-Enhancing Drugs Manufacturer Market Share
3.4.2 Top 6 Cognition-Enhancing Drugs Manufacturer Market Share
3.5 Global Cognition-Enhancing Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cognition-Enhancing Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cognition-Enhancing Drugs Market Size by Region
4.1.1 Global Cognition-Enhancing Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Cognition-Enhancing Drugs Revenue by Region (2016-2026)
4.2 North America Cognition-Enhancing Drugs Revenue (2016-2026)
4.3 Europe Cognition-Enhancing Drugs Revenue (2016-2026)
4.4 Asia-Pacific Cognition-Enhancing Drugs Revenue (2016-2026)
4.5 South America Cognition-Enhancing Drugs Revenue (2016-2026)
4.6 Middle East and Africa Cognition-Enhancing Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cognition-Enhancing Drugs Sales in Volume by Type (2016-2026)
5.2 Global Cognition-Enhancing Drugs Revenue by Type (2016-2026)
5.3 Global Cognition-Enhancing Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cognition-Enhancing Drugs Sales in Volume by Application (2016-2026)
6.2 Global Cognition-Enhancing Drugs Revenue by Application (2016-2026)
6.3 Global Cognition-Enhancing Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cognition-Enhancing Drugs Sales by Type (2016-2026)
7.2 North America Cognition-Enhancing Drugs Sales by Application (2016-2026)
7.3 North America Cognition-Enhancing Drugs Market Size by Country
7.3.1 North America Cognition-Enhancing Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Cognition-Enhancing Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cognition-Enhancing Drugs Sales by Type (2016-2026)
8.2 Europe Cognition-Enhancing Drugs Sales by Application (2016-2026)
8.3 Europe Cognition-Enhancing Drugs Market Size by Country
8.3.1 Europe Cognition-Enhancing Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Cognition-Enhancing Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Cognition-Enhancing Drugs Market Size by Region
9.3.1 Asia-Pacific Cognition-Enhancing Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cognition-Enhancing Drugs Sales by Type (2016-2026)
10.2 South America Cognition-Enhancing Drugs Sales by Application (2016-2026)
10.3 South America Cognition-Enhancing Drugs Market Size by Country
10.3.1 South America Cognition-Enhancing Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Cognition-Enhancing Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Cognition-Enhancing Drugs Market Size by Country
11.3.1 Middle East & Africa Cognition-Enhancing Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cognition-Enhancing Drugs Typical Distributors
12.3 Cognition-Enhancing Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cognition-Enhancing Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cognition-Enhancing Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Accelerated Intelligence Basic Information, Manufacturing Base and Competitors
Table 4. Accelerated Intelligence Major Business
Table 5. Accelerated Intelligence Cognition-Enhancing Drugs Product and Services
Table 6. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cognition Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Cognition Therapeutics Major Business
Table 9. Cognition Therapeutics Cognition-Enhancing Drugs Product and Services
Table 10. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cogstate Basic Information, Manufacturing Base and Competitors
Table 12. Cogstate Major Business
Table 13. Cogstate Cognition-Enhancing Drugs Product and Services
Table 14. Cogstate Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. HVMN Basic Information, Manufacturing Base and Competitors
Table 16. HVMN Major Business
Table 17. HVMN Cognition-Enhancing Drugs Product and Services
Table 18. HVMN Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 20. Biogen Idec Major Business
Table 21. Biogen Idec Cognition-Enhancing Drugs Product and Services
Table 22. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Cognition-Enhancing Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 24. Global Cognition-Enhancing Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Cognition-Enhancing Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Cognition-Enhancing Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 27. Head Office and Cognition-Enhancing Drugs Production Site of Key Manufacturer
Table 28. Cognition-Enhancing Drugs New Entrant and Capacity Expansion Plans
Table 29. Cognition-Enhancing Drugs Mergers & Acquisitions in the Past Five Years
Table 30. Global Cognition-Enhancing Drugs Sales by Region (2016-2021e) & (K MT)
Table 31. Global Cognition-Enhancing Drugs Sales by Region (2021-2026) & (K MT)
Table 32. Global Cognition-Enhancing Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Cognition-Enhancing Drugs Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 35. Global Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 36. Global Cognition-Enhancing Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Cognition-Enhancing Drugs Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Cognition-Enhancing Drugs Price by Type (2016-2021e) & (USD/MT)
Table 39. Global Cognition-Enhancing Drugs Price by Type (2021-2026) & (USD/MT)
Table 40. Global Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 41. Global Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 42. Global Cognition-Enhancing Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Cognition-Enhancing Drugs Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Cognition-Enhancing Drugs Price by Application (2016-2021e) & (USD/MT)
Table 45. Global Cognition-Enhancing Drugs Price by Application (2021-2026) & (USD/MT)
Table 46. North America Cognition-Enhancing Drugs Sales by Country (2016-2021e) & (K MT)
Table 47. North America Cognition-Enhancing Drugs Sales by Country (2021-2026) & (K MT)
Table 48. North America Cognition-Enhancing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Cognition-Enhancing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 51. North America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 52. North America Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 53. North America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 54. Europe Cognition-Enhancing Drugs Sales by Country (2016-2021e) & (K MT)
Table 55. Europe Cognition-Enhancing Drugs Sales by Country (2021-2026) & (K MT)
Table 56. Europe Cognition-Enhancing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Cognition-Enhancing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 59. Europe Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 60. Europe Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 61. Europe Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 62. Asia-Pacific Cognition-Enhancing Drugs Sales by Region (2016-2021e) & (K MT)
Table 63. Asia-Pacific Cognition-Enhancing Drugs Sales by Region (2021-2026) & (K MT)
Table 64. Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 67. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 68. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 69. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 70. South America Cognition-Enhancing Drugs Sales by Country (2016-2021e) & (K MT)
Table 71. South America Cognition-Enhancing Drugs Sales by Country (2021-2026) & (K MT)
Table 72. South America Cognition-Enhancing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Cognition-Enhancing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 75. South America Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 76. South America Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 77. South America Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 78. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2016-2021e) & (K MT)
Table 79. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2021-2026) & (K MT)
Table 80. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2016-2021e) & (K MT)
Table 83. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2021-2026) & (K MT)
Table 84. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2016-2021e) & (K MT)
Table 85. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2021-2026) & (K MT)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Cognition-Enhancing Drugs Typical Distributors
Table 89. Cognition-Enhancing Drugs Typical Customers
List of Figures
Figure 1. Cognition-Enhancing Drugs Picture
Figure 2. Global Cognition-Enhancing Drugs Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Cognition-Enhancing Drugs Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Drug Stores
Figure 8. Retail Pharmacies
Figure 9. Global Cognition-Enhancing Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Cognition-Enhancing Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Cognition-Enhancing Drugs Sales (2016-2026) & (K MT)
Figure 12. Global Cognition-Enhancing Drugs Price by Type (2016-2026) & (USD/MT)
Figure 13. Global Cognition-Enhancing Drugs Production Capacity (2016-2026) & (K MT)
Figure 14. Global Cognition-Enhancing Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Cognition-Enhancing Drugs Market Drivers
Figure 16. Cognition-Enhancing Drugs Market Restraints
Figure 17. Cognition-Enhancing Drugs Market Trends
Figure 18. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturer in 2020
Figure 19. Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturer in 2020
Figure 20. Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Cognition-Enhancing Drugs Sales Market Share by Region (2016-2026)
Figure 24. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2016-2026)
Figure 25. North America Cognition-Enhancing Drugs Revenue (2016-2026) & (USD Million)
Figure 26. Europe Cognition-Enhancing Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Cognition-Enhancing Drugs Revenue (2016-2026) & (USD Million)
Figure 28. South America Cognition-Enhancing Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Cognition-Enhancing Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Global Cognition-Enhancing Drugs Sales Market Share by Type (2016-2026)
Figure 31. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2016-2026)
Figure 32. Global Cognition-Enhancing Drugs Price by Type (2016-2026) & (USD/MT)
Figure 33. Global Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 34. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2016-2026)
Figure 35. Global Cognition-Enhancing Drugs Price by Application (2016-2026) & (USD/MT)
Figure 36. North America Cognition-Enhancing Drugs Sales Market Share by Type (2016-2026)
Figure 37. North America Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 38. North America Cognition-Enhancing Drugs Sales Market Share by Country (2016-2026)
Figure 39. North America Cognition-Enhancing Drugs Revenue Market Share by Country (2016-2026)
Figure 40. United States Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Cognition-Enhancing Drugs Sales Market Share by Type (2016-2026)
Figure 44. Europe Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 45. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2016-2026)
Figure 46. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2016-2026)
Figure 47. Germany Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Cognition-Enhancing Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Cognition-Enhancing Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Cognition-Enhancing Drugs Sales Market Share by Country (2016-2026)
Figure 65. South America Cognition-Enhancing Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Cognition-Enhancing Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の肝性脳症治療薬市場 2021：企業別、地域別、種類・用途別 The Hepatic Encephalopathy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界のまつげ美容液市場 2021：企業別、地域別、種類・用途別 The Eyelash Enhancing Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の変形性関節症治療薬市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の肝性脳症治療薬市場 2021：企業別、地域別、種類・用途別 The Hepatic Encephalopathy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の粘膜類天疱瘡治療薬市場 2021：企業別、地域別、種類・用途別 The Mucous Membrane Pemphigoid Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…